🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-08-08
Trial ID
NCT05941585
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
The vast majority of patients with ALL will die of the disease, and no stan...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2016-01-01
Trial ID
NCT03318419
Treatments Being Tested
The vast majority of patients with AML will die of the disease, and no stan...
Status
Unknown
Location
Liang Wang
Start Date
2016-01-01
Trial ID
NCT03181815
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
The goal of this phase 2 trial is to test the safety and efficacy of CHG Co...
Status
Not Yet Recruiting
Location
Navy General Hospital
Start Date
2024-09-20
Trial ID
NCT06470841
Treatments Being Tested
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
This is a Phase I/II clinical study to determine the maximum tolerated dose...
Status
Terminated
Location
Research Site
Start Date
2017-07-31
Trial ID
NCT03217838
Treatments Being Tested
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321